These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 17216258)

  • 1. Effect of haemodialysis on markers of bone turnover in children.
    Waller S; Ridout D; Rees L
    Pediatr Nephrol; 2007 Apr; 22(4):586-92. PubMed ID: 17216258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Accuracy of Bone Turnover Markers and Bone Histology in Patients With CKD Treated by Dialysis.
    Sprague SM; Bellorin-Font E; Jorgetti V; Carvalho AB; Malluche HH; Ferreira A; D'Haese PC; Drüeke TB; Du H; Manley T; Rojas E; Moe SM
    Am J Kidney Dis; 2016 Apr; 67(4):559-66. PubMed ID: 26321176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlations and time course of FGF23 and markers of bone metabolism in maintenance hemodialysis patients.
    Bielesz BO; Hecking M; Plischke M; Cejka D; Kieweg H; Haas M; Marculescu R; Hörl WH; Bieglmayer C; Sunder-Plassmann G
    Clin Biochem; 2014 Sep; 47(13-14):1316-9. PubMed ID: 24956265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patients.
    Coen G; Ballanti P; Bonucci E; Calabria S; Centorrino M; Fassino V; Manni M; Mantella D; Mazzaferro S; Napoletano I; Sardella D; Taggi F
    Nephrol Dial Transplant; 1998 Sep; 13(9):2294-302. PubMed ID: 9761512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between plasma levels of sclerostin, calcium-phosphate disturbances, established markers of bone turnover, and inflammation in haemodialysis patients.
    Pietrzyk B; Wyskida K; Ficek J; Kolonko A; Ficek R; Więcek A; Olszanecka-Glinianowicz M; Chudek J
    Int Urol Nephrol; 2019 Mar; 51(3):519-526. PubMed ID: 30584645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy.
    Jehle PM; Ostertag A; Schulten K; Schulz W; Jehle DR; Stracke S; Fiedler R; Deuber HJ; Keller F; Boehm BO; Baylink DJ; Mohan S
    Kidney Int; 2000 Feb; 57(2):423-36. PubMed ID: 10652019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences between "intact" PTH and 1-84 PTH assays in chronic renal failure and dialysis.
    Waller S; Ridout D; Cantor T; Rees L
    Pediatr Nephrol; 2005 Feb; 20(2):197-9. PubMed ID: 15627166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secretion of parathyroid hormone oscillates depending on the change in serum ionized calcium during hemodialysis and may affect bone metabolism.
    Kitahara T; Ueki K; Kuroiwa T; Kaneko Y; Hiromura K; Nojima Y
    Nephron Clin Pract; 2005; 101(1):c9-17. PubMed ID: 15886497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Accuracy of Biomarkers and Imaging for Bone Turnover in Renal Osteodystrophy.
    Salam S; Gallagher O; Gossiel F; Paggiosi M; Khwaja A; Eastell R
    J Am Soc Nephrol; 2018 May; 29(5):1557-1565. PubMed ID: 29555831
    [No Abstract]   [Full Text] [Related]  

  • 10. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients.
    Lee SH; Huang TS; Hsieh SJ
    Miner Electrolyte Metab; 1996; 22(4):219-23. PubMed ID: 8807625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone alkaline phosphatase isoforms in hemodialysis patients with low versus non-low bone turnover: a diagnostic test study.
    Haarhaus M; Monier-Faugere MC; Magnusson P; Malluche HH
    Am J Kidney Dis; 2015 Jul; 66(1):99-105. PubMed ID: 25843703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of chronic renal failure on bone turnover and bone alkaline phosphatase isoforms.
    Magnusson P; Sharp CA; Magnusson M; Risteli J; Davie MW; Larsson L
    Kidney Int; 2001 Jul; 60(1):257-65. PubMed ID: 11422759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bone biomarkers in haemodialysis patients: bone alkaline phosphatase or ß-Crosslaps?].
    Jean G; Souberbielle JC; Granjon S; Lorriaux C; Hurot JM; Mayor B; Deleaval P; Chazot C
    Nephrol Ther; 2013 Jun; 9(3):154-9. PubMed ID: 23545236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe secondary hyperparathyroidism in patients on haemodialysis is associated with a high initial serum parathyroid hormone and beta-CrossLaps level: Results from an incident cohort.
    Jean G; Lafage-Proust MH; Souberbielle JC; Lechevallier S; Deleaval P; Lorriaux C; Hurot JM; Mayor B; Mehdi M; Chazot C
    PLoS One; 2018; 13(6):e0199140. PubMed ID: 29912988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone biopsy results and serum bone turnover parameters in uremic children.
    Ziólkowska H; Pańiczyk-Tomaszewska M; Debiński A; Polowiec Z; Sawicki A; Sieniawska M
    Acta Paediatr; 2000 Jun; 89(6):666-71. PubMed ID: 10914959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical markers of bone turnover in the diagnosis of renal osteodystrophy in dialyzed children.
    Baskin E; Beşbaş N; Saatçi U; Hasçelik G; Topaloğlu R; Ozen S; Bakkaloğlu A
    Turk J Pediatr; 2004; 46(1):28-31. PubMed ID: 15074371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serum beta-type I collagen carboxyterminal telopeptide (beta-CTXs) and bone involvement in chronic renal failure].
    Oliveri B; Wittich AC; Nadal MA; Zeni SN
    Medicina (B Aires); 2005; 65(4):321-8. PubMed ID: 16193710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of calcitriol and maxacalcitol on secondary hyperparathyroidism in patients on chronic haemodialysis: a randomized prospective multicentre trial.
    Hayashi M; Tsuchiya Y; Itaya Y; Takenaka T; Kobayashi K; Yoshizawa M; Nakamura R; Monkawa T; Ichihara A
    Nephrol Dial Transplant; 2004 Aug; 19(8):2067-73. PubMed ID: 15187195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum markers of low-turnover bone disease in Mexican children with chronic kidney disease undergoing dialysis.
    Avila-Díaz M; Matos M; García-López E; Prado MD; Castro-Vázquez F; Ventura MD; González E; Amato D; Paniagua R
    Perit Dial Int; 2006; 26(1):78-84. PubMed ID: 16538879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Alkaline phosphatase of bone origin in hemodialyzed patients. 110 assays].
    Ureña P; Prieur P; Pétrover M
    Presse Med; 1996 Oct; 25(29):1320-5. PubMed ID: 8942941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.